Insider · CIK 0001257599
Daniel A Ninivaggi
director
Files at INDV (Indivior Pharmaceuticals, Inc.), GTX (Garrett Motion Inc.). First filing Jan 7, 2026, latest Jan 7, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$27k bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 20Weak | Indivior Pharmaceuticals, Inc. | $27k 775 shares | +5% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | GTX Garrett Motion Inc. | AGrant or award Common Stock | +1,333 | - | - | 131,765 | 7 d ago |
| Jan 26, 2026 | INDV Indivior Pharmaceuticals, Inc. | AGrant or award Common Stock | +3,722 | $0.00 | $0 | 20,645 | Jan 28, 2026 |
| Jan 5, 2026 | INDV Indivior Pharmaceuticals, Inc. | POpen-market purchase Ordinary Shares10b5-1 | +775 | $35.39 | $27k | 16,923 | Jan 7, 2026 |
| Jan 2, 2026 | GTX Garrett Motion Inc. | AGrant or award Common Stock | +2,014 | - | - | 140,181 | Jan 5, 2026 |
| Oct 1, 2025 | GTX Garrett Motion Inc. | AGrant or award Common Stock | +3,571 | - | - | 138,167 | Oct 3, 2025 |
| Jul 1, 2025 | GTX Garrett Motion Inc. | AGrant or award Common Stock | +4,551 | - | - | 134,596 | Jul 3, 2025 |
| May 22, 2025 | GTX Garrett Motion Inc. | AGrant or award Common Stock | +13,417 | - | - | 130,045 | May 27, 2025 |
| Apr 1, 2025 | GTX Garrett Motion Inc. | AGrant or award Common Stock | +6,142 | - | - | 116,628 | Apr 3, 2025 |
| Jan 2, 2025 | GTX Garrett Motion Inc. | AGrant or award Common Stock | +5,577 | - | - | 110,486 | Jan 6, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.